SHA:603439 Revenue

Guizhou Sanli Pharmaceutical Co.,Ltd had revenue of 408.59M CNY in the quarter ending March 31, 2025, a decrease of -3.18%. This brings the company's revenue in the last twelve months to 2.13B, up 24.76% year-over-year. In the year 2024, Guizhou Sanli Pharmaceutical Co.,Ltd had annual revenue of 2.14B with 31.16% growth.

Revenue (ttm)

2.13B

Revenue Growth

+24.76%

P/S Ratio

2.54

Revenue / Employee

747.18K

Employees

2,852

Market Cap

5.41B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.14B	509.41M	31.16%
Dec 31, 2023	1.63B	433.66M	36.10%
Dec 31, 2022	1.20B	262.35M	27.94%
Dec 31, 2021	938.97M	308.74M	48.99%
Dec 31, 2020	630.22M	-253.56M	-28.69%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Sichuan Biokin Pharmaceutical	5.82B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings